Role of ceramides in barrier function of healthy and diseased skin

被引:148
作者
Choi, MJ
Maibach, HI
机构
[1] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA
[2] Charmzone Res & Dev Ctr, Wonju, Kangwon Do, South Korea
关键词
D O I
10.2165/00128071-200506040-00002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Stratum corneum intercellular lipids play an important role in the regulation of skin water barrier homeostasis and water-holding capacity. Modification of intercellular lipid organization and composition may impair these properties. Patients with skin diseases such as atopic dermatitis, psoriasis, contact dermatitis, and some genetic disorders have diminished skin barrier function. Lipid composition in diseased skin is characterized by decreased levels of ceramide and altered ceramide profiles. To clarify mechanisms underlying ceramides as a causative factor of skin disease, investigators have examined the activity of enzymes in the stratum corneum on ceramide production and degradation. The activities of ceramidase, sphingomyelin deacylase, and glucosylceramide deacylase are increased in epidermal atopic dermatitis. Investigators have also compared the expression levels of sphingolipid activator protein in the epidermis of normal and diseased skin. A decreased level of prosaposin has been identified in both atopic dermatitis and psoriasis. These results indicate that decreased ceramide level is a major etiologic factor in skin diseases. Hence, topical skin lipid supplementation may provide opportunities for controlling ceramide deficiency and improving skin condition.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 63 条
[31]   Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis [J].
Jensen, JM ;
Fölster-Holst, R ;
Baranowsky, A ;
Schunck, M ;
Winoto-Morbach, S ;
Neumann, C ;
Schütze, S ;
Proksch, E .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (06) :1423-1431
[32]  
JIN K, 1994, ACTA DERM-VENEREOL, V74, P337
[33]   The therapeutic potential of modulating the ceramide/sphingomyelin pathway [J].
Kolesnick, R .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (01) :3-8
[34]   Evidence for the association of ultraviolet-C and H2O2-induced apoptosis with acid sphingomyelinase activation [J].
Komatsu, M ;
Takahashi, T ;
Abe, T ;
Takahashi, I ;
Ida, H ;
Takada, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2001, 1533 (01) :47-54
[35]   Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction [J].
Kucharekova, M ;
Schalkwijk, J ;
Van de Kerkhof, PCM ;
Van de Valk, PGM .
CONTACT DERMATITIS, 2002, 46 (06) :331-338
[36]   Localization of sphingomyelinase in lesional skin of atopic dermatitis patients [J].
Kusuda, S ;
Cui, CY ;
Takahashi, M ;
Tezuka, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (05) :733-738
[37]  
Lucci A, 1999, CANCER-AM CANCER SOC, V86, P300, DOI 10.1002/(SICI)1097-0142(19990715)86:2<300::AID-CNCR14>3.0.CO
[38]  
2-H
[39]   Deficiency of epidermal protein-bound ω-hydroxyceramides in atopic dermatitis [J].
Macheleidt, O ;
Kaiser, HW ;
Sandhoff, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) :166-173
[40]  
Man MMQ, 1996, J INVEST DERMATOL, V106, P1096